China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina, just minutes ...
The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions in packaging weight and waste, maximizing storage space and saving on ...
Hosted on MSN1mon
Illumina targets high single-digit revenue growth by 2027 amid NovaSeq X transitionHe noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...
The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...
Illumina exhibited stable performance in its latest earnings, meeting revenue estimates while navigating rising expenses and legal costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results